Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer (Q77758319)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Hidefumi Sasaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Masayuki Tanahashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Haruhiro Yukiue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Satoru Moiriyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Yoshihiro Kobayashi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Yoshiaki Nakashima

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Masahiro Kaji

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Masanobu Kiriyama

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Ichiro Fukai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Yosuke Yamakawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Yoshitaka Fujii

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

71-76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy for non-small cell lung cancer: the experience of the Lung Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Apoptosis. Its significance in cancer and cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Terminal differentiation of human breast cancer through PPAR gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Peroxisome proliferator-activated receptor gamma1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

The LightCycler: a microvolume multisample fluorimeter with rapid temperature control.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

MMP-2: expression, activation and inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

Disruption of epithelial cell-matrix interactions induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

1 reference

7 January 2021

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900449-4

7 January 2021

10.1016/S0169-5002(01)00449-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11891036%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference